by Amanda Kabage | Jun 15, 2020
We renamed the treatment of FMT to IMT: Intestinal Microbiota Transplantation. This was published in the American Journal of Gastroenterology in 2019. Click here. Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new...
by Amanda Kabage | Jun 12, 2020
On this day, the FDA workshop classified FMT as a drug and a biologic. Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to email a link to a friend (Opens in...
by Amanda Kabage | Jun 12, 2020
The FDA announced the enforcement discretion policy with respect to regulation of FMT. This policy allows physicians to use FMT without federal regulatory oversight in the treatment of C. difficile infections that do not respond to standard therapies. Share this:Click...
by Amanda Kabage | Jun 12, 2020
Development of GMP protocols began at MCT. Our program was working in collaboration with a start-up company called NuQure, which later became CIPAC, then Crestovo, and ultimately Finch Therapeutics. Share this:Click to share on Twitter (Opens in new window)Click to...
by Amanda Kabage | Jun 12, 2020
The first treatment with capsule preparation of freeze-dried microbiota was done in January 2015. Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to email a...
